NCT00762658View on ClinicalTrials.gov

A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 7, 2007

Study Completion Date

December 7, 2007

Conditions

Psoriasis

Interventions

DRUG

AN2728 Ointment, 5%

DRUG

AN2728 Ointment, 2%

DRUG

AN2728 Ointment, 0.5%

DRUG

AN2728 Ointment Vehicle

DRUG

Betnesol®-V Creme, 0.1%

DRUG

Protopic® Ointment, 0.1 %

Trial Locations (1)

10117

Bioskin GmbH, Hamburg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT00762658 - A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test | Biotech Hunter | Biotech Hunter